Found: 97
Select item for more details and to access through your institution.
IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1370972
- By:
- Publication type:
- Article
Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR‐mutated NSCLC with high thrombospondin‐1 expression.
- Published in:
- Cancer Science, 2024, v. 115, n. 8, p. 2718, doi. 10.1111/cas.16199
- By:
- Publication type:
- Article
Treatment patterns and clinical outcomes of resectable clinical stage III non‐small cell lung cancer in a Japanese real‐world setting: Surgery cohort analysis of the SOLUTION study.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 20, p. 1541, doi. 10.1111/1759-7714.15305
- By:
- Publication type:
- Article
Induction of resistance to neurotrophic tropomyosin‐receptor kinase inhibitors by HMGCS2 via a mevalonate pathway.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cam4.7393
- By:
- Publication type:
- Article
Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1384733
- By:
- Publication type:
- Article
Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1384731
- By:
- Publication type:
- Article
A Case of Immune Aplastic Anemia during Combined Treatment with Atezolizumab and Chemotherapy for Non-Small Cell Lung Cancer.
- Published in:
- Journal of Nippon Medical School, 2024, v. 91, n. 3, p. 339, doi. 10.1272/jnms.JNMS.2024_91-302
- By:
- Publication type:
- Article
Exploring effective biomarkers and potential immune related gene in small cell lung cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-58454-4
- By:
- Publication type:
- Article
Clinicopathological Characteristics of Everolimus-Associated Interstitial Lung Disease: A Single-Center Consecutive Analysis.
- Published in:
- Journal of Nippon Medical School, 2024, v. 91, n. 2, p. 207, doi. 10.1272/jnms.JNMS.2024_91-211
- By:
- Publication type:
- Article
Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention—prospective, single-center, randomized, parallel-group study
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-02895-0
- By:
- Publication type:
- Article
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 2, p. 115, doi. 10.1007/s10147-023-02436-5
- By:
- Publication type:
- Article
Smoking-Related Interstitial Fibrosis and Smoker's Macrophages.
- Published in:
- Journal of Nippon Medical School, 2024, v. 91, n. 1, p. 20, doi. 10.1272/jnms.JNMS.2024_91-113
- By:
- Publication type:
- Article
Influence of background cardiovascular risk factors on VEGF inhibitor-related adverse vascular events in patients with non-small cell lung cancer: a retrospective study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 13, p. 12435, doi. 10.1007/s00432-023-05092-4
- By:
- Publication type:
- Article
Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic Carcinoma.
- Published in:
- Internal Medicine, 2023, v. 62, n. 18, p. 2731, doi. 10.2169/internalmedicine.1142-22
- By:
- Publication type:
- Article
Osimertinib early dose reduction as a risk to brain metastasis control in EGFR‐mutant non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 17731, doi. 10.1002/cam4.6393
- By:
- Publication type:
- Article
Platinum‐combination chemotherapy with or without immune‐checkpoint inhibitor in patients with postoperative recurrent non‐small cell lung cancer previously treated with adjuvant platinum‐doublet chemotherapy: A multicenter retrospective study
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 21, p. 2069, doi. 10.1111/1759-7714.14992
- By:
- Publication type:
- Article
Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 7, p. 872, doi. 10.1007/s10147-023-02343-9
- By:
- Publication type:
- Article
Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 3, p. 411, doi. 10.1007/s10637-023-01358-3
- By:
- Publication type:
- Article
Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Standard versus low‐dose nab‐paclitaxel in previously treated patients with advanced non‐small cell lung cancer: A randomized phase II trial (JMTO LC14‐01).
- Published in:
- Cancer Medicine, 2023, v. 12, n. 8, p. 9133, doi. 10.1002/cam4.5652
- By:
- Publication type:
- Article
Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report.
- Published in:
- OncoTargets & Therapy, 2023, v. 16, p. 65, doi. 10.2147/OTT.S398375
- By:
- Publication type:
- Article
Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184363
- By:
- Publication type:
- Article
Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 15, p. 2142, doi. 10.1111/1759-7714.14527
- By:
- Publication type:
- Article
Effectiveness of Corticosteroid Therapy for Non-Severe COVID-19 in Patients Not Requiring Supplemental Oxygen Who Have Risk Factors for Severe Disease.
- Published in:
- Journal of Nippon Medical School, 2022, v. 89, n. 4, p. 422, doi. 10.1272/jnms.JNMS.2022_89-409
- By:
- Publication type:
- Article
The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 13, p. 1940, doi. 10.1111/1759-7714.14463
- By:
- Publication type:
- Article
Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report.
- Published in:
- OncoTargets & Therapy, 2022, v. 15, p. 637, doi. 10.2147/OTT.S361467
- By:
- Publication type:
- Article
Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma.
- Published in:
- Molecular & Clinical Oncology, 2022, v. 16, n. 4, p. N.PAG, doi. 10.3892/mco.2022.2520
- By:
- Publication type:
- Article
Alpha‐actinin‐4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 1002, doi. 10.1111/cas.15228
- By:
- Publication type:
- Article
Machine Learning Prediction for Supplemental Oxygen Requirement in Patients with COVID-19.
- Published in:
- Journal of Nippon Medical School, 2022, v. 89, n. 2, p. 161, doi. 10.1272/jnms.JNMS.2022_89-210
- By:
- Publication type:
- Article
Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Evaluation of a Tool that Enables Cancer Patients to Participate in the Decision-Making Process during Treatment Selection.
- Published in:
- Journal of Nippon Medical School, 2021, v. 88, n. 4, p. 273, doi. 10.1272/jnms.JNMS.2021_88-401
- By:
- Publication type:
- Article
Possible, Non-Invasive Method of Measuring Dynamic Lung Compliance in Patients with Interstitial Lung Disease Using Photoplethysmography.
- Published in:
- Journal of Nippon Medical School, 2021, v. 88, n. 4, p. 326, doi. 10.1272/jnms.JNMS.2021_88-411
- By:
- Publication type:
- Article
Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 6, p. 1065, doi. 10.1007/s10147-021-01893-0
- By:
- Publication type:
- Article
Exosome‐derived miR‐210 involved in resistance to osimertinib and epithelial–mesenchymal transition in EGFR mutant non‐small cell lung cancer cells.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 11, p. 1690, doi. 10.1111/1759-7714.13943
- By:
- Publication type:
- Article
Long Non-Coding RNA CRNDE Is Involved in Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant Lung Cancer via eIF4A3/MUC1/EGFR Signaling.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 8, p. 4005, doi. 10.3390/ijms22084005
- By:
- Publication type:
- Article
EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Functional inhibition of heat shock protein 70 by VER‐155008 suppresses pleural mesothelioma cell proliferation via an autophagy mechanism.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 4, p. 491, doi. 10.1111/1759-7714.13784
- By:
- Publication type:
- Article
Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 18, p. 6597, doi. 10.1002/cam4.3306
- By:
- Publication type:
- Article
Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 9, p. 2465, doi. 10.1111/1759-7714.13557
- By:
- Publication type:
- Article
Bevacizumab plus chemotherapy in nonsquamous non‐small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 7, p. 1876, doi. 10.1111/1759-7714.13472
- By:
- Publication type:
- Article
Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo.
- Published in:
- Journal of Nippon Medical School, 2020, v. 87, n. 3, p. 118, doi. 10.1272/jnms.JNMS.2020_87-302
- By:
- Publication type:
- Article
A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101-.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 5, p. 867, doi. 10.1007/s10147-020-01629-6
- By:
- Publication type:
- Article
Survival Analysis for Patients with ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. 306, doi. 10.1634/theoncologist.2019-0728
- By:
- Publication type:
- Article
Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 4, p. 1052, doi. 10.1111/1759-7714.13364
- By:
- Publication type:
- Article
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 12, p. 1543, doi. 10.1007/s10147-019-01516-9
- By:
- Publication type:
- Article